Literature DB >> 11171323

Characterization and chromosomal localization of JAM-1, a platelet receptor for a stimulatory monoclonal antibody.

U P Naik1, M U Naik, K Eckfeld, P Martin-DeLeon, J Spychala.   

Abstract

We have previously reported the purification and characterization of a 32 kDa platelet surface glycoprotein that is recognized by the stimulatory monoclonal antibody, F11. The cDNA has been cloned and found to encode the human homolog of the murine junctional adhesion molecule, JAM; we therefore named this human homolog JAM-1. Northern blot analysis indicated that JAM-1 mRNA is expressed as multiple species, the predominant transcript being approximately 4.0 kb in size. Genetic mapping analysis using fluorescence in situ hybridization (FISH) showed that it is localized to chromosome 1q21.1-21.3. Recombinant JAM-1, when expressed in Chinese hamster ovary (CHO) cells, localized to the cell membrane with intense staining where two adjacent cells actually made contact with each other, suggesting that, similar to murine JAM, human JAM-1 may also localize at the cell-cell junction. In well-spread cells, JAM-1 co-localized with F-actin at the cell-cell contacts and at the membrane ruffles, but not at the stress fibers. Interestingly, JAM-1 localizes only to the cell-cell junctions formed by two transfected cells and not to the cell-cell junctions formed by a transfected cell with an untransfected cell, suggesting that JAM-1 may facilitate cell adhesion through homophilic binding. In addition, human platelets specifically bind to a monolayer of CHO cells expressing human JAM-1, further supporting homophilic interactions. The results presented here indicate that JAM-1, a receptor for a platelet-activating antibody, is the human homolog of the junctional adhesion molecule. JAM-1 is a single copy gene, which is constitutively expressed on various tissues and cells, and may be involved in cell to cell adhesion through homophilic interaction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171323     DOI: 10.1242/jcs.114.3.539

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  14 in total

1.  TNF-α and IFN-γ promote lymphocyte adhesion to endothelial junctional regions facilitating transendothelial migration.

Authors:  Justyna Jaczewska; Midhat H Abdulreda; Chi Y Yau; Martin M Schmitt; Irene Schubert; Per-Olof Berggren; Christian Weber; Rory R Koenen; Vincent T Moy; Ewa P Wojcikiewicz
Journal:  J Leukoc Biol       Date:  2013-09-26       Impact factor: 4.962

Review 2.  Mechanisms of reovirus bloodstream dissemination.

Authors:  Karl W Boehme; Caroline M Lai; Terence S Dermody
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

3.  Contra-regulation of calcium- and integrin-binding protein 1-induced cell migration on fibronectin by PAK1 and MAP kinase signaling.

Authors:  Meghna U Naik; Ulhas P Naik
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

4.  Mesenchymal stem cells with modification of junctional adhesion molecule a induce hair formation.

Authors:  Minjuan Wu; Xiaocan Guo; Ling Yang; Yue Wang; Ying Tang; Yongji Yang; Houqi Liu
Journal:  Stem Cells Transl Med       Date:  2014-02-20       Impact factor: 6.940

5.  A comparative molecular force spectroscopy study of homophilic JAM-A interactions and JAM-A interactions with reovirus attachment protein sigma1.

Authors:  Sri Ram Krishna Vedula; Tong Seng Lim; Eva Kirchner; Kristen M Guglielmi; Terence S Dermody; Thilo Stehle; Walter Hunziker; Chwee Teck Lim
Journal:  J Mol Recognit       Date:  2008 Jul-Aug       Impact factor: 2.137

6.  Putting the brakes on cancer cell migration: JAM-A restrains integrin activation.

Authors:  Ulhas P Naik; Meghna U Naik
Journal:  Cell Adh Migr       Date:  2008-10-06       Impact factor: 3.405

7.  Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding.

Authors:  Andrea E Prota; Jacquelyn A Campbell; Pierre Schelling; J Craig Forrest; Melissa J Watson; Timothy R Peters; Michel Aurrand-Lions; Beat A Imhof; Terence S Dermody; Thilo Stehle
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

8.  Junctional adhesion molecule-A suppresses platelet integrin αIIbβ3 signaling by recruiting Csk to the integrin-c-Src complex.

Authors:  Meghna U Naik; Jeffrey L Caplan; Ulhas P Naik
Journal:  Blood       Date:  2013-12-03       Impact factor: 22.113

9.  The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1.

Authors:  Sentot Santoso; Ulrich J H Sachs; Hartmut Kroll; Monica Linder; Andreas Ruf; Klaus T Preissner; Triantafyllos Chavakis
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

10.  N-glycosylation controls the function of junctional adhesion molecule-A.

Authors:  David W Scott; Caitlin E Tolbert; David M Graham; Erika Wittchen; James E Bear; Keith Burridge
Journal:  Mol Biol Cell       Date:  2015-07-29       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.